Floatz logo

Cytomegalovirus -Specific Cytotoxic T Cells

Adenovirus

Jessie L. AlexanderCell therapyPhase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Adenovirus cohort.

Asset / SponsorPhaseRating
Adenovirus Specific T- Lymphocytes
Jessie L. Alexander
Phase 1/2CCC
Epstein-Barr Virus Specific T-Lymphocytes
Jessie L. Alexander
Phase 1/2CCC
Ebv Specific T-Lymphocytes
Jessie L. Alexander, MD
Phase 1/2CC

Same molecule, other indications

Cytomegalovirus -Specific Cytotoxic T Cells is also rated in:

leukemiaDormant
CCC
Indicative ·
48 / 100
View asset →
lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →
cytomegalovirus infectionDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →